Effects of cangrelor in coronary artery disease patients with and without diabetes mellitus: an in vitro pharmacodynamic investigation-Reference-Cited by-同舟云学术

Effects of cangrelor in coronary artery disease patients with and without diabetes mellitus: an in vitro pharmacodynamic investigation

Published:2012-11-25 Issue:2 Volume:35 Page:155-164
ISSN:0929-5305
Container-title:Journal of Thrombosis and Thrombolysis
language:en
Short-container-title:J Thromb Thrombolysis

Author:

Ferreiro José L.,Ueno Masafumi,Tello-Montoliu Antonio,Tomasello Salvatore D.,Capodanno Davide,Capranzano Piera,Dharmashankar Kodlipet,Darlington Andrew,Desai Bhaloo,Rollini Fabiana,Guzman Luis A.,Bass Theodore A.,Angiolillo Dominick J.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Hematology

Link

http://link.springer.com/content/pdf/10.1007/s11239-012-0846-z.pdf

Reference40 articles.

1. Geisler T, Anders N, Paterok M et al (2007) Platelet response to clopidogrel is attenuated in diabetic patients undergoing coronary stent implantation. Diabetes Care 30:372–374

2. Angiolillo DJ, Fernandez-Ortiz A, Bernardo E et al (2005) Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment. Diabetes 54:2430–2435

3. Serebruany V, Pokov I, Kuliczkowski W, Chesebro J, Badimon J (2008) Baseline platelet activity and response after clopidogrel in 257 diabetics among 822 patients with coronary artery disease. Thromb Haemost 100:76–82

4. Lüscher TF, Creager MA, Beckman JA, Cosentino F (2003) Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. Circulation 108:1655–1661

5. Ferreiro JL, Angiolillo DJ (2011) Diabetes and antiplatelet therapy in acute coronary syndrome. Circulation 123:798–813

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiplatelet efficacy of ticagrelor versus clopidogrel in Mediterranean patients with diabetes mellitus and chronic coronary syndromes: A crossover pharmacodynamic investigation;Frontiers in Cardiovascular Medicine;2022-11-22

2. Impact of diabetes mellitus on the pharmacodynamic effects of prasugrel and ticagrelor after switching from clopidogrel in patients with coronary artery disease;Journal of Thrombosis and Thrombolysis;2022-09-01

3. Association of fractalkine with functional severity of heart failure and impact on clopidogrel efficacy in patients with ischemic heart disease;Thrombosis Research;2020-12

4. Pharmacokinetics and Pharmacodynamics of Approved and Investigational P2Y12 Receptor Antagonists;Clinical Pharmacokinetics;2020-02-13

5. Cangrelor or Clopidogrel in Patients with Type 2 Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials;Diabetes Therapy;2019-03-23